IL1A and metabolic dysfunction-associated steatotic liver disease: Also, it was described that MSCs-Exo promote fatty acid oxidation and reduce lipogenesis and expression of inflammatory factors TNF-α, IL-1, and IL-6 in the liver in oleic–palmitic acid-treated hepatic cells and HFD-induced NAFLD mice [56].